Form D · Biotechnology
Origin Life Sciences, Inc.
Princeton, NJ · CIK 0001573901
Offering snapshot reported Oct 17, 2023 · SEC filing
- Reported sold
- $51K Offering amount: $5M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $1K Reported outside-investor minimum
- First sale
- Aug 18, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 17, 2023 | Initial | $51,000 | No comparison | 2 | SEC filing |
| Jun 22, 2023 | Amendment | $659,600 | $159,600vs Jun 1, 2023 | 6 | SEC filing |
| Jun 1, 2023 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Sep 7, 2022 | Initial | $500,000 | No comparison | 7 | SEC filing |
| May 15, 2017 | Initial | $1,332,100 | No comparison | 32 | SEC filing |
| Apr 8, 2013 | Initial | $500,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $3.57K
- Finders' fees
- $0
- Form D file number
- 021-495034
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Boustead Securities, LLC | 141391 |
Source: Form D, filed Oct 17, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Issac Anthony Iii | Executive |
| Anthony Brampton | Director |
| Tony Brampton | Director |
| David Dantzker | Director, Executive |
| David Dantzker, Md | Director, Executive |
| Alex Dolgopolsky, Md | Executive |
| Alex Dolgopolsky, Ph D | Executive |
| John Fernandes | Executive |
| Johnny Fernandes | Executive |
| Betsy Hanna | Executive |
| Jerome Boda Korten | Director |
| Vic Micati | Director |
| Victor Micati | Director |
| Howard Nelson | Director |
| Mike Pohl | Executive |
| Michael Pohl | Executive |
| Michael David Preston | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2 Research Way Third Floor
Princeton, NJ, 08540
Princeton, NJ, 08540